Ms Yolanda Cora, | |
506 W Jackman St, Lancaster, CA 93534 | |
(661) 726-2850 | |
(661) 726-2854 |
Full Name | Ms Yolanda Cora |
---|---|
Gender | Female |
Speciality | Rehabilitation Practitioner |
Location | 506 W Jackman St, Lancaster, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083100697 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
225400000X | Rehabilitation Practitioner | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Yolanda Cora, 506 W Jackman St, Lancaster, CA 93534-2531 Ph: (661) 726-2850 | Ms Yolanda Cora, 506 W Jackman St, Lancaster, CA 93534 Ph: (661) 726-2850 |
News Archive
Emdeon Inc. opened for trading today on the New York Stock Exchange under the ticker symbol "EM" after its successful initial public offering in which it raised $367 million in gross proceeds. Headquartered in Nashville, Tenn., Emdeon is the 13th IPO by an operating company, including non-U.S. companies, and the 10th U.S. domestic IPO to list on the New York Stock Exchange this year.
Electronic health records and embedded tools can alert and direct pediatricians so they can better manage the weight of children and teenagers, according to a new Kaiser Permanente study published online in The Journal of Pediatrics.
Depomed, Inc. announced today it has received guidance from the FDA in formal meeting minutes from a meeting held in December regarding SeradaTM, the company's extended release gabapentin product candidate for the treatment of menopausal hot flashes. Based on guidance reflected in the meeting minutes, Depomed plans to conduct a single additional pivotal Phase 3 trial evaluating Serada for the treatment of menopausal hot flashes.
In 2006, University of North Carolina at Chapel Hill researchers published a study that found people with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels.
› Verified 7 days ago